Alibaba Health's FY2021 Financial Performance: Net Profit Up 198.5%

Healthcare Author: 林怡龄 Editor: 刘聪 May 25, 2021 09:05 PM (GMT+8)

The revenue of Alibaba Health in the fiscal year 2021 hit CNY 15.52 billion, finally breaking even.

Ali health

According to Alibaba Health's latest financial report: 

- Total revenue was CNY 15.52 billion in the fiscal year 2021, with a year-on-year growth of 61.7%.

- Among four major businesses, the self-operated business of medicine is the main contributing force of its revenue, amounting to CNY 13.216 billion, or about 85% of the total revenue. The rest is contributed by pharmaceutical e-commerce platform business, medical health service business and digital infrastructure business, with revenue of CNY 1.965 billion, CNY 284 million and CNY 53 million respectively.

- During the same period, the drug revenue of Ali health pharmacy rose by 86.1% year on year, and the proportion of drug revenue increased to 64.8%.

- The proportion of drug delivery service orders increased from 34.9% to 50.1% for 100 core cities, in terms of warehousing and logistics.

- The gross profit was CNY 3.62 billion, which extended 62.1% year-on-year.

- The net profit was CNY 630 million, with a year-on-year growth of 198.5%, turning the deficit into a surplus annually.

截屏2021-11-10 18.58.04.png.png

- The total commodity transaction volume (GMV) of the Tmall medical platform operated by Alibaba health reached CNY 123.2 billion, providing over 33 million SKUs to over 280 million active consumers.

- Ali health further enhances its online services, including both medical and health services. During the reporting period, its daily online inquiring service volume has exceeded 180 thousand times; the annual number of active users for the Alipay medical health channel exceeded 520 million.

- The share price of Ali health rose 1.86% to HKD 21.85, with a total market value of approximately HKD 294.7 billion.